In recent years, the pharmaceutical supply chain has endured a raft of disruptions. From the Russia-Ukraine war and Red Sea shipping attacks to the pandemic, Brexit and international trade tariffs, the industry has faced a barrage of regulatory, logistical and cost challenges.
In such a volatile environment, reliance on constrained supply chains and internal capacity can leave pharma manufacturers lacking the resilience to withstand persistent disruption, putting operations in jeopardy.
In response, toll processors have evolved to become collaborative partners that play a strategic role by enabling manufacturers to overcome shortages, remain compliant and maintain the uninterrupted supply of vital medicines.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.